Immunological and prognostic significance of tumour necrosis in colorectal cancer.
Journal Information
Full Title: Br J Cancer
Abbreviation: Br J Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests TTS is the CEO and co-owner of Healthfund Finland Oy, and reports interview honoraria from Boehringer Ingelheim Finland and Amgen Finland."
Funding Disclosure
Evidence found in paper:
"Funding This study was funded by Cancer Foundation Finland (59-5619 to JPV). Open Access funding provided by University of Oulu including Oulu University Hospital."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025